|
ZNF74 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.382400E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.264200E-01 |
| Normal-vs-Stage2 |
9.175600E-01 |
| Normal-vs-Stage3 |
9.879000E-01 |
| Normal-vs-Stage4 |
9.517200E-01 |
| Stage1-vs-Stage2 |
4.127000E-01 |
| Stage1-vs-Stage3 |
4.456000E-01 |
| Stage1-vs-Stage4 |
4.480200E-01 |
| Stage2-vs-Stage3 |
9.361200E-01 |
| Stage2-vs-Stage4 |
8.782000E-01 |
| Stage3-vs-Stage4 |
9.444000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.889200E-01 |
| Normal-vs-AfricanAmerican |
4.521600E-02 |
| Normal-vs-Asian |
2.155600E-02 |
| Caucasian-vs-AfricanAmerican |
1.582340E-02 |
| Caucasian-vs-Asian |
4.632300E-02 |
| AfricanAmerican-vs-Asian |
3.603200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.898600E-01 |
| Normal-vs-Female |
3.646800E-01 |
| Male-vs-Female |
2.784400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.322400E-01 |
| Normal-vs-Age(41-60Yrs) |
4.506200E-01 |
| Normal-vs-Age(61-80Yrs) |
8.962400E-01 |
| Normal-vs-Age(81-100Yrs) |
3.340000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.808200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.851200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.430960E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.356600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.078800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.356000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.858300E-03 |
| Normal-vs-Grade 2 |
5.791200E-01 |
| Normal-vs-Grade 3 |
7.720000E-01 |
| Normal-vs-Grade 4 |
6.995200E-01 |
| Grade 1-vs-Grade 2 |
3.483600E-02 |
| Grade 1-vs-Grade 3 |
6.221400E-03 |
| Grade 1-vs-Grade 4 |
1.153770E-02 |
| Grade 2-vs-Grade 3 |
7.315800E-01 |
| Grade 2-vs-Grade 4 |
3.232600E-01 |
| Grade 3-vs-Grade 4 |
5.271400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
9.582600E-01 |
| Normal-vs-ccB subtype |
6.287000E-01 |
| ccA subtype-vs-ccB subtype |
5.961600E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.132000E-01 |
| Normal-vs-N1 |
5.352400E-01 |
| N0-vs-N1 |
3.614000E-01 |
|
|
